LUNDBECK PHARMA A/S: Financial statements 2024
CVR: 56750215
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
LUNDBECK PHARMA A/S (CVR 56750215) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 18,343,000 and a net result of DKK 1,820,000 compared with DKK 991,000 the year before. That is an increase of 14.9% compared with the year before. The profit margin was 9.9%. Equity in the 2024 report amounted to DKK 3,484,000. The solvency ratio was 17.8%. The company had 20 employees in the financial year.
- Revenue
- DKK 18,343,000
- Gross Profit
- DKK 1,851,000
- Profit/Loss
- DKK 1,820,000
- Equity
- DKK 3,484,000
- Total Assets
- DKK 19,618,000
- Employees
- 20
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 18.3M | 1.9M | 1.8M | 3.5M | 20 |
| 2023 | 16M | 2.6M | 991K | 2.5M | - |
| 2022 | 17M | 2.3M | 982K | 2.3M | - |
| 2021 | 16.5M | 3.2M | 1.2M | 2.4M | 20 |
| 2020 | 19.2M | 1.3M | -5.1M | -1.6M | 20 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of September 16, 2024, Søren Klein-Kristensen has joined the board of directors of LUNDBECK PHARMA A/S.
As of September 16, 2024, Dierk Erwin Schoch has left the board of directors of LUNDBECK PHARMA A/S.
LUNDBECK PHARMA A/S has won the tender "Amgros 2024 1.1060.a" issued by Amgros I/S worth 686,000,000 DKK.
As of April 2, 2024, Michala Fischer-Hansen has joined the board of directors of LUNDBECK PHARMA A/S.
As of April 2, 2024, Ole Wendler Pedersen has left the board of directors of LUNDBECK PHARMA A/S.
LUNDBECK PHARMA A/S has published its annual report for 2023. Revenue came to DKK 15,968,000, and the net result was DKK 991,000.
As of February 26, 2024, Ole Wendler Pedersen has joined the board of directors of LUNDBECK PHARMA A/S.
As of February 26, 2024, Jacob Tolstrup has left the board of directors of LUNDBECK PHARMA A/S.
About LUNDBECK PHARMA A/S
LUNDBECK PHARMA A/S is a Danish company of the type Aktieselskab based in Valby, founded in 1958. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named HANS LUNDBECK A/S. The management consists of Søren Klein-Kristensen. The board consists of Michala Fischer-Hansen (chair), Søren Klein-Kristensen and Thomas Bo Bjørn Klee. The company is owned by H. LUNDBECK A/S. The company has 17 employees (2026). In 2025, the company reported revenue of DKK 18,887,000 and a net result of DKK 2,291,000 compared with DKK 1,820,000 the year before. Equity in the 2025 report amounted to DKK 3,378,000.